BIOMAT Database Logo BIOMAT Database Logo

Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. 2012

Jussara M do Carmo, and Alexandre A da Silva, and John S Rushing, and John E Hall
Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS 39216-4505, USA. jdocarmo@umc.edu

We have previously demonstrated that leptin-mediated activation of the central nervous system (CNS) melanocortin system reduces appetite and increases sympathetic activity and blood pressure (BP). In the present study we examined whether endogenous melanocortin system activation, independent of leptin's actions, contributes to the regulation of BP and metabolic functions in obese Zucker rats, which have mutated leptin receptors. The long-term cardiovascular and metabolic effects of central melanocortin-3/4 receptor (MC3/4R) antagonism with SHU-9119 were assessed in lean (n = 6) and obese (n = 8) Zucker rats. BP and heart rate (HR) were measured 24-h/day by telemetry and an intracerebroventricular cannula was placed in the brain lateral ventricle. After stable control measurements, SHU-9119 was infused intracerebroventricularlly (1 nmol/h) for 10 days followed by a 10-day recovery period. Chronic CNS MC3/4R antagonism significantly increased food intake and body weight in lean (20 ± 1 to 45 ± 2 g and 373 ± 11 to 432 ± 14 g) and obese (25 ± 2 to 35 ± 2 g and 547 ± 10 to 604 ± 11 g) rats. No significant changes were observed in plasma glucose levels in lean or obese rats, whereas plasma leptin and insulin levels markedly increased in lean Zucker rats during CNS MC3/4R antagonism. Chronic SHU-9119 infusion in obese Zucker rats reduced mean arterial pressure (MAP) and HR by 6 ± 1 mmHg and 24 ± 5 beats/min, whereas in lean rats SHU-9119 infusion reduced HR by 31 ± 9 beats/min while causing only a transient decrease in MAP. These results suggest that in obese Zucker rats the CNS melanocortin system contributes to elevated BP independent of leptin receptor activation.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D009074 Melanocyte-Stimulating Hormones Peptides with the ability to stimulate pigmented cells MELANOCYTES in mammals and MELANOPHORES in lower vertebrates. By stimulating the synthesis and distribution of MELANIN in these pigmented cells, they increase coloration of skin and other tissue. MSHs, derived from pro-opiomelanocortin (POMC), are produced by MELANOTROPHS in the INTERMEDIATE LOBE OF PITUITARY; CORTICOTROPHS in the ANTERIOR LOBE OF PITUITARY, and the hypothalamic neurons in the ARCUATE NUCLEUS OF HYPOTHALAMUS. MSH,Melanocyte Stimulating Hormone,Melanocyte-Stimulating Hormone,Melanophore Stimulating Hormone,Melanotropin,MSH (Melanocyte-Stimulating Hormones),Melanophore-Stimulating Hormone,Hormone, Melanocyte Stimulating,Hormone, Melanocyte-Stimulating,Hormone, Melanophore Stimulating,Melanocyte Stimulating Hormones,Stimulating Hormone, Melanocyte,Stimulating Hormone, Melanophore
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011924 Rats, Zucker Two populations of Zucker rats have been cited in research--the "fatty" or obese and the lean. The "fatty" rat (Rattus norvegicus) appeared as a spontaneous mutant. The obese condition appears to be due to a single recessive gene. Zucker Rat,Zucker Rats,Rat, Zucker
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal

Related Publications

Jussara M do Carmo, and Alexandre A da Silva, and John S Rushing, and John E Hall
Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats.
August 2001, American journal of physiology. Regulatory, integrative and comparative physiology,
Jussara M do Carmo, and Alexandre A da Silva, and John S Rushing, and John E Hall
Activation of the central nervous system in obese Zucker rats during food deprivation.
December 2001, The Journal of comparative neurology,
Jussara M do Carmo, and Alexandre A da Silva, and John S Rushing, and John E Hall
Effects of fluoxetine administration on hypothalamic melanocortin system in obese Zucker rats.
June 2008, Neuropeptides,
Jussara M do Carmo, and Alexandre A da Silva, and John S Rushing, and John E Hall
Decreased central and peripheral catecholaminergic activation in obese Zucker rats.
October 1995, Endocrinology,
Jussara M do Carmo, and Alexandre A da Silva, and John S Rushing, and John E Hall
Increased sensitivity to somatostatin in obese Zucker rats.
January 1985, Clinical physiology and biochemistry,
Jussara M do Carmo, and Alexandre A da Silva, and John S Rushing, and John E Hall
Activation of the melanocortin-4 receptor causes enhanced excitation in presympathetic paraventricular neurons in obese Zucker rats.
January 2011, Regulatory peptides,
Jussara M do Carmo, and Alexandre A da Silva, and John S Rushing, and John E Hall
Arterial blood pressure and aortic responses in obese, age-grouped Zucker rats.
January 2010, Methods and findings in experimental and clinical pharmacology,
Jussara M do Carmo, and Alexandre A da Silva, and John S Rushing, and John E Hall
Central administration of melanocortin agonist increased insulin sensitivity in diet-induced obese rats.
March 2007, FEBS letters,
Jussara M do Carmo, and Alexandre A da Silva, and John S Rushing, and John E Hall
Altered pressure-natriuresis in obese Zucker rats.
June 1999, Hypertension (Dallas, Tex. : 1979),
Jussara M do Carmo, and Alexandre A da Silva, and John S Rushing, and John E Hall
Age-dependent changes in blood pressure and arterial reactivity in obese Zucker rats.
September 2003, European journal of pharmacology,
Copied contents to your clipboard!